Having trouble accessing articles? Reset your cache.

GS-9973: Interim Phase II data

Interim data from 78 evaluable patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or non-Hodgkin's lymphoma (NHL) in the single-arm, open-label,

Read the full 224 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE